|
|
Other links at Articles > Diabetes and Endocrinology |
| 1. |
Enzyme Replacement Improves Cardiomyopathy in Anderson-Fabry Disease
|
|
|
Enzyme replacement with agalsidase alfa results in regression of hypertrophic cardiomyopathy in patients with Anderson-Fabry disease, an X-linked glycosphingolipid storage disorder caused by alpha-galactosidase A deficiency, according to a report in the February issue of Heart. Reuters Health Information
|
|
|